Vers une nouvelle pharmacologie des récepteurs NMDA: modulateurs allostériques positifs et négatifs ciblant des sous-unités spécifiques. – NMDAR Pharma

Pierre PAOLETTI (Organisme de recherche)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Help of the ANR 150,000 euros
Beginning and duration of the scientific project: - 36 Months

• List of selected projects
• Permanent link to this summary on the ANR website (ANR-05-JCJC-0005)
• See the publications in the HAL-ANR portal